4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-007468
Options or other derivatives
- Chief Financial Officer acquired 69,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2018-02-01 | Grant or award · Stock option (right to buy) | +54,000 | 54,000 | D: show line 1 in the form | |||||
| Ruffo Frank Chief Financial Officer | 2018-02-01 | Grant or award · Restricted stock units | +15,500 | 15,500 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…